June 23

Pharmalot, Pharmalittle: The Stada saga concludes

first_img GET STARTED What is it? National Biotech Reporter Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of “The Readout LOUD” podcast. Good morning, all. Damian Garde here filling in for Ed Silverman on this, the start of another week replete with meetings, deadlines, and all the other trappings of working life. Here are some headlines from around the pharma world to get your morning started. May you conquer all that you must this week, and do keep in touch.After months of rumor and negotiation, German drug maker Stada is finally getting sold, Bloomberg tells us. Private equity magnates Bain Capital and Cinven have teamed up to pay $5.6 billion for Stada, a figure that is nearly 50 percent above its value before takeout talks began. Bain and Cinven have agreed to honor the company’s union contracts and refrain from layoffs for four years. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. By Damian Garde April 10, 2017 Reprints Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED [email protected] Log In | Learn More Pharmalot center_img About the Author Reprints Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. What’s included? Damian Garde Pharmalot, Pharmalittle: The Stada saga concludes @damiangarde Alex Hogan/STAT Tags financepharmaceuticalslast_img read more